Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Denosumab Protects Bone Loss and Function in Patients With Osteoporotic Vertebral Compression Fracture After Percutaneous Vertebroplasty: a Randomized Placebo-controlled Clinical Trial

NCT05058443 is registered in ClinicalTrials.gov with Shenzhen People's Hospital as lead sponsor.

NCT NCT05058443
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05058443 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Denosumab Protects Bone Loss and Function in Patients With Osteoporotic Vertebral Compression Fracture After Percutaneous Vertebroplasty: a Randomized Placebo-controlled Clinical Trial
Lead sponsor
Shenzhen People's Hospital
Phase
Phase 2/3
Overall status
Completed
Start date
January 6, 2020
Completion date
August 10, 2022
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

osteoporotic vertebral compression fracture